The stock has experienced significant volatility over the past six months, peaking above $329 in late December 2025 before a sharp decline to around $283 in mid-March 2026. The overall trend from the start of the provided data (Oct 2025 at ~$307) to the current price of $294.16 shows a slight net decline, indicating a period of consolidation and recent pressure. Over the last month, the stock is down 2.04%, underperforming the S&P 500, which fell 5.25%, showing relative strength of +3.21%. Over the last three months, JPM has declined 8.71%, underperforming the broader market's 4.63% decline, as indicated by a relative strength of -4.08%. The current price of $294.16 is near the lower end of its 52-week range ($202.16 to $337.25), representing a drawdown of approximately 12.8% from its high. The recent bounce from the March lows suggests potential support, but the stock remains in a downtrend from its December peak.

Revenue for Q4 2025 was $69.61B, showing a year-over-year growth of 3.88%. However, quarterly revenue has sequentially declined from Q3's $71.90B and Q2's $69.91B. Net income for Q4 was $13.03B, resulting in a healthy net margin of 18.7%. Profitability remains strong, with a trailing ROE of 15.74% and an ROA of 1.35%. The company maintains a solid financial position with a high current ratio of 14.85, indicating strong short-term liquidity. The debt-to-equity ratio stands at 1.38, which is a moderate level for a major bank. Free cash flow over the trailing twelve months is a robust $100.87B, providing ample capacity for shareholder returns and investments.